Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Liberman, Uri; Weiss, Stuart; Bröll, Johann; W. Minne, H.; Quan, Hui; H. Bell, Norman; Adolfo Rodriguez-Portales, Jose; W. Downs, Robert; Dequeker, J.; J. Favus, Murray; Seeman, Ego; R. Recker, Robert; Capizzi, Thomas; C. Santora, Arthur; Lombardi, Antonio; V. Shah, Raksha; Hirsch, Laurence; Karpf, David

doi:10.1056/nejm199511303332201

Public

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Published in New England Journal of Medicine • Nov 30, 1995

Authors:

Uri Liberman

Stuart Weiss

Johann Bröll

Abstract

BACKGROUND: Postmenopausal osteoporosis is a serious health problem, and additional treatments are needed. METHODS: We studied the effects of oral alendronate, an aminobisphosphonate, on bone mineral density and the incidence of fractures and height loss in 994 women with postmenopausal osteoporosis...

Subject

Medicine

Bone mineral

Osteoporosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!